Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,201,989
-
Share change
-
-699,747
-
Total reported value
-
$70,984,650
-
Price per share
-
$59.06
-
Number of holders
-
48
-
Value change
-
-$41,248,475
-
Number of buys
-
20
-
Number of sells
-
20
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q2 2017
As of 30 Jun 2017,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,201,989 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, UBS Group AG, RAYMOND JAMES & ASSOCIATES, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, Raymond James Financial Services Advisors, Inc., STUYVESANT CAPITAL MANAGEMENT, CITADEL ADVISORS LLC, and Psagot Investment House Ltd..
This page lists
48
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.